We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Outlines Safety Data Needed for COVID-19 Vaccine EUAs for Children and Adolescents
FDA Outlines Safety Data Needed for COVID-19 Vaccine EUAs for Children and Adolescents
The FDA would need to see safety data from at least 3,000 trial participants to grant Emergency Use Authorization or approval for a COVID-19 vaccine for children under age 12, an agency official told members of its vaccine advisory panel yesterday.